Factors associated with readmissions in women participating in screening programs and treated for breast cancer: a retrospective cohort study

Table 3 Patient complications associated with treatment, recurrence and vital status according to readmission

	Readmitted, n (%) (n = 234)			Not readmitted, n (%) (n = 821)	p-value¹
	Early readmission (n = 76)	Late readmission (n = 87)	Long-term readmission (n = 71)	Not readmitted, n (%) (n = 821)	p-value¹
Complications associated with treatment²
Any complication³	34 (44.7)^a	44 (50.6)^b	38 (53.5)^c	182 (22.2)^a,b,c	< 0.001
General complications⁴	20 (26.3)^a	21 (24.1)^b	22 (31.0)^c	105 (12.8)^a,b,c	< 0.001
Surgical complications⁵	18 (23.7)	14 (16.1)	13 (18.3)	110 (13.4)	0.076
Medical complications⁶	22 (28.9)^a	29 (33.3)^b	26 (36.6)^c	80 (9.7)^a,b,c	< 0.001
Recurrence
No recurrence	66 (86.8)^a	71 (81.6)^b	16 (22.5)^c	743 (90.5)^a,b,c	< 0.001
Recurrence	10 (13.2)^a	16 (18.4)^b	55 (77.5)^c	78 (9.5)^a,b,c	< 0.001
Vital status
Alive	66 (86.8)^a	75 (86.2)^b	30 (42.3)^c	728 (88.7)^a,b,c	< 0.001
Dead	10 (13.2)^a	12 (13.8)^b	41 (57.7)^c	93 (11.3)^a,b,c	< 0.001

¹ Chi-square test
² The categories are not exclusive as the same patient could have more than one complication
³ Number of women with at least one complication
⁴ Included: pain and anxiety
⁵ Included: lymphedema, adhesions, skin infection and soft tissue necrosis
⁶ Included: treatment toxicity, endometrial alterations, hypothyroidism, mycosis, vascular insufficiency, asthenia, palpitations, mastitis, and depression
^a,b,c Values of the same row and subtable that share the same subscript are significantly different in p < .05 in the two-sided equality test for column proportions

ISSN: 1472-6963